Thoroughbred Financial Services’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.76M | Sell |
15,024
-5,690
| -27% | -$2.18M | 0.4% | 52 |
|
2025
Q1 | $7.16M | Buy |
20,714
+1,224
| +6% | +$423K | 0.45% | 43 |
|
2024
Q4 | $5.85M | Buy |
19,490
+697
| +4% | +$209K | 0.36% | 51 |
|
2024
Q3 | $7.64M | Sell |
18,793
-294
| -2% | -$119K | 0.49% | 42 |
|
2024
Q2 | $6.13M | Buy |
19,087
+4,278
| +29% | +$1.37M | 0.41% | 50 |
|
2024
Q1 | $4.94M | Sell |
14,809
-5,102
| -26% | -$1.7M | 0.48% | 48 |
|
2023
Q4 | $5.39M | Buy |
19,911
+1,153
| +6% | +$312K | 0.44% | 47 |
|
2023
Q3 | $4.61M | Buy |
18,758
+6,106
| +48% | +$1.5M | 0.45% | 48 |
|
2023
Q2 | $3.84M | Sell |
12,652
-1,021
| -7% | -$310K | 0.5% | 44 |
|
2023
Q1 | $3.61M | Buy |
13,673
+225
| +2% | +$59.3K | 0.53% | 44 |
|
2022
Q4 | $3.23M | Buy |
13,448
+1,091
| +9% | +$262K | 0.53% | 47 |
|
2022
Q3 | $2.27M | Buy |
12,357
+389
| +3% | +$71.5K | 0.43% | 56 |
|
2022
Q2 | $2.01M | Sell |
11,968
-605
| -5% | -$102K | 0.37% | 70 |
|
2022
Q1 | $3.15M | Buy |
12,573
+3,668
| +41% | +$919K | 0.52% | 45 |
|
2021
Q4 | $2.29M | Buy |
8,905
+2,324
| +35% | +$597K | 0.48% | 44 |
|
2021
Q3 | $1.6M | Buy |
6,581
+169
| +3% | +$41K | 0.39% | 63 |
|
2021
Q2 | $1.33M | Buy |
6,412
+462
| +8% | +$95.5K | 0.33% | 75 |
|
2021
Q1 | $1.12M | Sell |
5,950
-255
| -4% | -$48K | 0.31% | 82 |
|
2020
Q4 | $1.02M | Buy |
6,205
+330
| +6% | +$54.2K | 0.32% | 80 |
|
2020
Q3 | $732K | Sell |
5,875
-1,265
| -18% | -$158K | 0.28% | 88 |
|
2020
Q2 | $693K | Buy |
7,140
+267
| +4% | +$25.9K | 0.29% | 93 |
|
2020
Q1 | $618K | Buy |
+6,873
| New | +$618K | 0.22% | 125 |
|